Aardvark Therapeutics Announces Pricing of Initial Public Offering
SAN DIEGO, Feb. 12, 2025 (GLOBE NEWSWIRE) -- (“Aardvark”) (Nasdaq: AARD), a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to activate innate ...
Business Insider6d
Aardvark Therapeutics Announces Pricing of Initial Public Offering
Cantor Fitzgerald & Co., 110 East 59th Street, 6th Floor, New York, NY 10022, or by email at [email protected]; and RBC Capital Markets, LLC, Attention: Equity Capital Markets, 200 Vesey ...
Aardvark Therapeutics, Inc.: Aardvark Therapeutics Announces Pricing of Initial Public Offering
Aardvark Therapeutics, Inc. ("Aardvark") (Nasdaq: AARD), a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics ...
Nasdaq6d
Aardvark Therapeutics, Inc. Announces Pricing of Initial Public Offering at $16.00 per Share
Cantor Fitzgerald & Co., 110 East 59th Street, 6th Floor, New York, NY 10022, or by email at [email protected]; and RBC Capital Markets, LLC, Attention: Equity Capital Markets, 200 Vesey ...
RBC Capital Reaffirms Their Buy Rating on Barclays (BARC)
RBC Capital analyst Benjamin Toms maintained a Buy rating on Barclays (BARC – Research Report) on February 14 and set a price target of ...
Nasdaq5d
BNY to Speak at the RBC Capital Markets Global Financial Institutions Conference
will speak at the RBC Capital Markets Global Financial Institutions Conference in New York at 2:00 p.m. ET on Tuesday, March 4, 2025. The discussion may include forward-looking statements and ...